Santen Pharmaceutical Co., Ltd. Stock Börse Stuttgart
Stocks
SZD
JP3336000009
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.25 EUR | +2.50% |
|
-1.92% | +17.24% |
| Market Cap | 605B 3.78B 3.26B 3B 2.82B 5.3B 357B 5.34B 35.51B 13.83B 175B 14.18B 13.88B | P/E 2026 |
15.7x | P/E 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise Value | 552B 3.45B 2.97B 2.73B 2.57B 4.84B 325B 4.88B 32.41B 12.62B 160B 12.94B 12.66B | EV / Sales 2026 |
1.89x | EV / Sales 2027 * | 1.88x |
| Free-Float |
96.71% | Yield 2026 |
2.13% | Yield 2027 * | 2.21% |
| 23-09-29 | ETF der Woche: Back to the Roots | |
| 23-09-28 | ETF van de week: terug naar de basis | |
| 23-09-28 | L'ETF della settimana: ritorno ai fondamentali | |
| 23-09-28 | ETF de la semaine : Retour aux fondamentaux | |
| 21-02-15 | Nicox S A : A suivre aujourd'hui |
| 1 week | -2.91% | ||
| Current month | -2.91% | ||
| 3 months | +9.89% | ||
| 6 months | +16.28% | ||
| Current year | +14.94% |
| 1 week | 9.95 |  | 10.6 |
| 1 month | 9.8 | | 10.8 |
| 3 years | 7.6 | | 11.5 |
| 5 years | 6.4 | | 13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 66 | 2022-08-31 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Rie Nakajima
COO | Chief Operating Officer | 48 | 2023-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Akira Kurokawa
CHM | Chairman | 73 | 2024-03-31 |
Ippei Kurihara
BRD | Director/Board Member | 45 | 2024-05-31 |
Noboru Kotani
BRD | Director/Board Member | 69 | 2022-06-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.50% | -1.92% | +2.04% | +28.21% | 3.78B | |
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | |
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | |
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | |
| +0.06% | +0.68% | +24.66% | +16.53% | 330B | |
| -0.01% | -0.59% | +27.97% | +15.90% | 280B | |
| +0.07% | -0.21% | +27.70% | +33.49% | 279B | |
| -0.12% | +0.99% | -40.86% | -47.29% | 196B | |
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | |
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | |
| Average | -0.56% | +0.41% | +18.90% | +40.52% | 374.58B | |
| Weighted average by Cap. | -0.57% | -0.49% | +29.48% | +65.99% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 289B 1.8B 1.56B 1.43B 1.35B 2.53B 170B 2.55B 16.96B 6.6B 83.6B 6.77B 6.63B | 304B 1.9B 1.64B 1.51B 1.42B 2.66B 179B 2.69B 17.85B 6.95B 87.93B 7.13B 6.97B |
| Net income | 32.4B 202M 174M 160M 151M 284M 19.08B 286M 1.9B 740M 9.36B 759M 743M | 38.44B 240M 207M 190M 179M 337M 22.64B 339M 2.25B 878M 11.11B 900M 881M |
| Net Debt | -52.93B -330M -285M -262M -247M -463M -31.18B -467M -3.11B -1.21B -15.3B -1.24B -1.21B | -34.22B -214M -184M -169M -159M -300M -20.16B -302M -2.01B -782M -9.89B -802M -785M |
| Date | Price | Change |
|---|---|---|
| 26-06-18 | 10.20 € | +2.00% |
| 26-06-17 | 10.00 € | -1.96% |
| 26-06-16 | 10.20 € | 0.00% |
| 26-06-15 | 10.20 € | -1.92% |
| 26-06-12 | 10.40 € | -0.95% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
Select your edition
All financial news and data tailored to specific country editions
